Home > Pressrelease > Dermal Filler Market size worth over $9.4bn by 2028

Dermal Filler Market size worth over $9.4bn by 2028

  • Published Date: January 12, 2022

Dermal Filler Market size is set to surpass USD 9.4 billion by 2028, according to a new research report by Global Market Insights Inc.

Growing emphasis of women on aesthetics, especially in developed countries will stimulate the dermal filler market growth during the forecast timeline. Several people, especially those aged above 40 years, are focusing on achieving youthful appearance. Thus, increasing preference for non-invasive cosmetic treatment will boost the demand for dermal fillers. Further, growing adoption of dermal fillers in treatment of lip enhancement, skin rejuvenation, wrinkle correction enhances facial aesthetics.


Recent advancements in filler materials will highly impact demand for dermal fillers. The U.S. Food & Drug Administration approved significant number of fillers for use in specific areas of face that will enable dermatologists to offer target treatment to consumers. The latest developments involve a hyaluronic acid filler for subtle enhancement of lips, that improves lip definition without increase in size. In addition, growing awareness among public regarding procedures along with high patient satisfaction rate post procedure will assist increase in demand for dermal fillers during the forecast timeframe.

Growing acceptance of cosmetic treatment for long-lasting results will augment demand for non-biodegradable fillers

Non-biodegradable segment in the dermal filler market valued at USD 120 million in 2021. Non-biodegradable or non-absorbable dermal fillers are developed as an alternative to biodegradable fillers to prolong the aesthetic outcome with a lower risk, less cost, enhanced potential and a quicker recovery duration. Additionally, rising preference for long-lasting treatments along with continuous developments will drive the segment growth in the coming years.

Benefits imparted by CaHA dermal fillers to propel the product demand

The dermal filler market for calcium hydroxylapatite (CaHA) segment captured USD 170 million in 2021. The CaHA filler restores healthy appearance and enhances aesthetics. The CaHA fillers are offering several features such as long-lasting nature and enhanced biocompatibility with human tissue. Further, several companies are involved in production of CaHA fillers.


Increasing usage of several aesthetic procedures among baby boomers will enhance the market value

Face lift segment is projected to witness 8.9% growth rate through 2028 led by the growing usage of soft tissue fillers to reshape and restore facial volume and lower skin sagging by filling the skin up from the inside and re-contour loose facial features. The rising adoption of liquid facial lift using dermal fillers as they are less expensive, carry lower risk of complications, minimal pain and least recovery time than other cosmetic alternatives will ultimately propel the demand for dermal filler in the coming years.

Browse key industry insights spread across 180 pages with 294 market data tables & 17  figures & charts from the report, “Dermal Filler Market Size By Type (Biodegradable {Temporary Biodegradable, Semi-permanent Biodegradable}, Non-biodegradable), By Material Type (Hyaluronic Acid {HA}, Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres {PMMA}), By Application (Facial Line Correction, Face Lift, Lip Enhancement), By End-use (Dermatology Clinics, Hospitals), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028 in detail along with the table of contents:

Rising establishment of dermatology-focusing facilities as well as availability of specialized treatments to boost the dermal filler market demand

Others end-use segment will account for significant revenue share during the forecast period. A significant increase in number of facilities such as clinics, medical spas and rejuvenation centers were witnessed in the recent years. Numerous facilities such as clinics, beauty centers, medical spas and other facilities are introducing various non-invasive treatments. These treatments are being rapidly adopted due to its cost-effectivity and shorter treatment duration. In addition to improving facilities, growing number of dermatologists and plastic surgeons in numerous countries will foster the demand for market.


Growing medical tourism in the Europe will offer lucrative development opportunities

Europe dermal filler market is estimated to attain a CAGR of 9.7% till 2028 impelled by the increasing awareness about facial aesthetics and growth in beauty consciousness. Rising demand for non-surgical aesthetic procedures, especially injectables in countries such as Italy, Spain and France will accelerate the industry expansion.


Moreover, benefits such as capability of fillers to enhance shape of nose and less expensive nature as compared to rhinoplasty will support demand for dermal fillers. Dermal fillers are capable of correcting imperfections and camouflaging areas over the skin that are concerning to patients. Countries such as the UK and Germany are largely preferred for such a procedure by Americans that will positively impact the industry value in these countries during the forecast timeframe.

Strategic collaborations and increasing R&D activities by several business players to influence expansion capabilities of the market leaders

Some of the notable companies operating in the market are Allergan plc (AbbVie)., Galderma S.A., Merz Aesthetics, Cytophil, Inc., Teoxane S.A., and Croma Pharma. These key participants are adopting several business growth strategies such as collaborations, mergers & acquisitions, partnerships and product launch to expand their market footprint.

Authors: Sumant Ugalmugle, Rupali Swain